Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) Are Potentially Valuable Tests for Diagnosing Periprosthetic Joint Infection

Wu, Hao; Pan, Liping; Meng, Zhichao; Liu, Heng; Yang, Xin; Cao, Yongping

doi:10.21203/rs.3.rs-376702/v1

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…32 Baseline reduction in the percentage of lymphocytes as a biomarker for prognosis in HF has been reported, but it has not yet been demonstrated in long-term follow-up as in our results. 33,34,35 Lymphopenia is also a marker for worse prognosis 13 in other systemic diseases including COVID-19. 36 The mechanisms responsible for the increment in the relative reduction in lymphocytes in HF are not fully understood.…”

Section: Discussionmentioning

confidence: 99%

Very Long-term Longitudinal Follow-up of Heart Failure on the REMADHE Trial

Bocchi,

Guimaraes,

Romero

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: Heart failure (HF) is associated with frequent hospitalization and worse prognosis. Prognosis factors and survival in very long-term follow-up have not been reported in HF. HF disease management programs(DMP) results are contradictory. DMP efficacy in very long-term follow-up is unknown. We studied the very long-term follow-up of up to 23.6 years and prognostic factors of HF in 412 patients under GDMT included in the REMADHE trial. Methods: The REMADHE trial was a prospective, single-center, randomized trial comparing DMP versus usual care(C). The first patient was randomized on October 5, 1999. The primary outcome of this extended REMADHE was all-cause mortality. Results: The all-cause mortality rate was 88.3%. HF was the first cause of death followed by death at home. Mortality was higher in the first 6-year follow-up. The predictive variables in multivariate analysis associated with mortality were age >52 years (P=0.015), Chagas etiology (P=0.010), LVEF <45% (P=0.008), use of digoxin (P=0.002), functional class IV (P=0.01), increase in urea (P=0.03), and reduction of lymphocytes (P=0.005). In very long-term follow-up, DMP did not affect mortality in patients under GDMT. HF as a cause of death was more frequent in the C group. Chagas disease, LVEF <45%, and renal function were associated with different modes of death. Conclusion: DMP was not effective in reducing very-long term mortality; however, the causes of death had changed. Our findings that age, LVEF, Chagas disease, functional class, renal function, lymphocytes, and digoxin use were associated with poor prognosis could influence future strategies to improve HF management.

show abstract

Section: Discussionmentioning

confidence: 99%